The global laboratory automation market size was valued at USD 7.2 Billion in 2024, and it is expected to reach USD 12.3 Billion by 2033, exhibiting a growth rate (CAGR) of 6.12% from 2025 to 2033.
To get more information on this market, Request Sample
The primary driver of the market is the increasing emphasis on error reduction in laboratories, which promotes the use of automated systems that minimize human interference while ensuring consistency and reliability in diagnostic and analytical results. In addition, rising demands for accuracy and scale in biomedical research require advancements in laboratory automation for single cell sequencing since automated systems facilitate high-throughput analysis, streamlined workflows, and faster insights, fueling innovations in drug development and personalized medicine. In April 2024, Parse Biosciences launched the laboratory automation provider program to collaborate with Hamilton, Opentrons Labworks, and SPT Labtech for automating its Evercode single cell products. This program aims to support faster insights for large-scale studies and drug development by enabling high-throughput single cell sequencing. The penetration of artificial intelligence and machine learning in laboratories is transforming the way data is processed and analyzed as AI-powered automation solutions have optimized decision-making processes by enhancing predictive capabilities and giving actionable insights in research and clinical applications.
The increasing need for efficient healthcare delivery is driving the adoption of advanced automation solutions in patient testing. These technologies address workflow inefficiencies and staffing challenges, enhancing diagnostic accuracy, streamlining operations, and improving overall productivity in medical laboratories. For example, on October 30, 2024, Siemens Healthineers unveiled automation solutions aimed at revolutionizing patient testing by addressing laboratory workflow inefficiencies and staffing shortages. These innovations focus on streamlining operations, enhancing productivity, and improving diagnostic accuracy, aligning with the growing demand for efficient healthcare delivery in increasingly strained medical environments. Another major growth factor is the increasing incidence of personalized medicine, which needs highly scalable and accurate laboratory flows for genetic testing, biomarker discovery, and therapeutic development tailored to a particular individual. Increasing the incidence of chronic diseases and the demands for a rapid diagnosis are also causing an acceleration of automation technologies in laboratories since it enables fast turn-around times and positive patient outcomes.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share on account of driven by advanced infrastructure, R&D investment, and technological innovation.
North America's dominance in the laboratory automation market stems from advanced healthcare infrastructure, significant investment in research and development, widespread adoption of innovative technologies, and the presence of leading automation companies. Moreover, cutting-edge platforms enable precise cellular analysis, enhancing research productivity and accuracy. These solutions address the growing need for efficient workflows in drug discovery, diagnostics, and life sciences, fostering progress in automated laboratory processes across various scientific and industrial applications. On March 5, 2024, the society for laboratory automation and screening (SLAS) in North America awarded CytoTronics' Pixel System the 2024 new product award. The innovative system enhances single-cell analysis by integrating advanced automation and precision technologies, supporting breakthroughs in research and diagnostic applications.
The Asia Pacific market is showing rapid growth with increasing investment in pharmaceuticals, biotechnology, and diagnostic facilities. In addition, the acceptance of advanced automation technologies in order to improve productivity together with the increased demand for precision in clinical and research laboratories is driving growth in this region.
Laboratory automation market in Europe is expanding, driven by healthy investments in R&D and cutting-edge healthcare infrastructure. The region emphasizes cost-cutting and efficiency in the functioning, mainly focusing on diagnostic and research laboratories. Increasing the adoption of highly advanced automated systems to smoothen workflows and increase accuracy speeds up the growth of the laboratory automation market across Europe.
The laboratory automation market of Latin America offers significant growth owing to the increase in the demand for healthcare and related research activities. Greater accessibility to health care, modernization initiatives that are government-backed, and the increasing usage of automation to reduce cost and raise diagnostic accuracy further propel the expansion of this market in the region.
The laboratory automation market in the Middle East and Africa is gaining momentum from significant investments in healthcare and research infrastructure. With a focus on regional health challenges, the region is embracing advanced automation technologies to help modernize laboratories, improve diagnostic accuracy, and enhance operational efficiency.
Some of the leading laboratory automation market companies include Danaher, PerkinElmer, Tecan Group, Thermo Fisher, Abbott Diagnostics, Agilent Technologies, Aurora Biomed, Becton, Dickinson and Company, Biomatrix, Biotech Instruments, Brooks Automation, Cerner, Eppendorf, Hamilton Storage Technologies, LabVantage Solutions, Labware, Olympus, Qiagen, Roche Holding, and Siemens Healthcare, among many others. On June 12, 2024, Thermo Fisher Scientific introduced the Heracell VIOS 250i AxD CO₂ incubators, designed for seamless integration into automated laboratories. These incubators feature automated door control, facilitating robotic handling and continuous cell therapy production, thereby enhancing efficiency and contamination control in cell culture processes.
Report Features | Details |
---|---|
Market Size in 2024 | USD 7.2 Billion |
Market Forecast in 2033 | USD 12.3 Billion |
Market Growth Rate 2025-2033 | 6.12% |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered | Modular Automation, Whole Lab Automation |
Equipment and Software Types Covered |
|
End-Users Covered | Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered | Danaher, PerkinElmer, Tecan Group, Thermo Fisher, Abbott Diagnostics, Agilent Technologies, Aurora Biomed, Becton, Dickinson and Company, Biomatrix, Biotech Instruments, Brooks Automation, Cerner, Eppendorf, Hamilton Storage Technologies, LabVantage Solutions, Labware, Olympus, Qiagen, Roche Holding, Siemens Healthcare, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |